NEW YORK (GenomeWeb) – Response Genetics today after the close of the market reported a 15 percent decrease year over year in its fourth quarter revenues.

For the three months ended Dec. 31, 2014, Response Genetics' total revenues decreased to $4.1 million from $4.8 million in the prior-year period.

Revenue from ResponseDX cancer tests was $3.7 million for the quarter ended Dec. 31, 2014, compared to $3.2 million for the prior-year period, an increase of 16 percent, but revenue from pharmaceutical clients dropped 67 percent to $400,000 in Q4 2014 from $1.6 million in 2013.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.